Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Semmler

Showing results (81-90 of 196) with videos related to

Pageof 20
Sort By:
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
Clinical Epidemiology|October 7, 2022
Applicability of Vasopressor Trials in Adult Critical Care: A Prospective Multicentre Meta-Epidemiologic Cohort StudyNina Buchtele, Michael Schwameis, Dominik Roth, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 19, 2026
Atherosclerosis burden across subtypes of steatotic liver disease: a European cohort analysisJohannes Bauer, Sophie Gensluckner, Julian Eberhardt, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2020
The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver diseaseBernhard Scheiner, Patrick G Northup, Anselm B Gruber, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Digestive Diseases and Sciences|June 19, 2019
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal HypertensionGeorg Semmler, Judith Stift, Bernhard Scheiner, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2021
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of MortalityGeorg Semmler, Sarah Wernly, Sebastian Bachmayer, et al.
Journal of Hepatology|January 13, 2024
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradientMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
United European Gastroenterology Journal|May 29, 2021
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failureLorenz Balcar, Georg Semmler, Katharina Pomej, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2023
An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosisLukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.
Pageof 20

Showing results (81-90 of 196) with videos related to

Sort By:
Pageof 20
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
Clinical Epidemiology|October 7, 2022
Applicability of Vasopressor Trials in Adult Critical Care: A Prospective Multicentre Meta-Epidemiologic Cohort StudyNina Buchtele, Michael Schwameis, Dominik Roth, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 19, 2026
Atherosclerosis burden across subtypes of steatotic liver disease: a European cohort analysisJohannes Bauer, Sophie Gensluckner, Julian Eberhardt, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2020
The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver diseaseBernhard Scheiner, Patrick G Northup, Anselm B Gruber, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.
Digestive Diseases and Sciences|June 19, 2019
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal HypertensionGeorg Semmler, Judith Stift, Bernhard Scheiner, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2021
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of MortalityGeorg Semmler, Sarah Wernly, Sebastian Bachmayer, et al.
Journal of Hepatology|January 13, 2024
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradientMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
United European Gastroenterology Journal|May 29, 2021
Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failureLorenz Balcar, Georg Semmler, Katharina Pomej, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2023
An impaired pituitary-adrenal signalling axis in stable cirrhosis is linked to worse prognosisLukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.
Pageof 20